CA
QTTB icon

CoreCap Advisors’s Q32 Bio QTTB Stock Holding History

CoreCap Advisors’s Portfolio QTTB Stock Details QTTB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-107
Closed -$177 – 3298
2025
Q1 		$177 Hold
107
– – ﹤0.01% 2999
2024
Q4 		$368 Buy
+107
New +$3.38K ﹤0.01% 2596
2022
Q4 		$252 Buy
+11
New +$292 ﹤0.01% 2251
2022
Q3 		– Sell
-11
Closed – – 2167
2022
Q2 		$0 Buy
+11
New +$376 ﹤0.01% 2300
2022
Q1 		– Sell
-11
Closed -$1K – 2165
2021
Q4 		$1K Buy
+11
New +$1.07K ﹤0.01% 2297

Other funds holding QTTB

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
CG
Carlyle Group Washington, District of Columbia $10.6B AUM 11.25% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
MAM
Monaco Asset Management Monaco $542M AUM 54.4% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
S
Sanofi Paris, France $336M AUM 126.85% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CoreCap Advisors's QTTB Position: Q2 2025 in Review

CoreCap Advisors sold out of Q32 Bio (QTTB) in Q2 2025, closing a stake of 107 shares — an estimated $177 sold.

CoreCap Advisors first reported a position in QTTB in Q4 2021 and held it in 5 quarters. The position peaked at $1K in Q4 2021. 61 funds tracked by Wall St. Rank hold QTTB as of Q2 2025.

  • CoreCap Advisors reported no remaining Q32 Bio position as of Q2 2025 after selling out during the quarter.
  • CoreCap Advisors sold 107 Q32 Bio shares in Q2 2025, an estimated $177.
  • CoreCap Advisors first reported a position in Q32 Bio in Q4 2021 and held it in 5 quarters.
  • CoreCap Advisors's Q32 Bio position peaked at $1K in Q4 2021.
  • 61 funds tracked by Wall St. Rank held Q32 Bio as of Q2 2025.

Based on CoreCap Advisors's 13F filing for Q2 2025, filed 14 Aug 2025.